Antibacterial and antiviral resin composition

By adding monovalent copper compound particles to the resin composition and adjusting the color brightness, the problem of insufficient performance of existing antibacterial and antiviral materials is solved, and efficient antibacterial and antiviral effects are achieved, and suitable for a variety of products.

CN118974176APending Publication Date: 2024-11-15NBC MESHTEC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380032163.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-03-31
Filing Date
2023-03-30
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

The existing antibacterial and antiviral materials have shortcomings in color and performance, and it is difficult to meet the high-brightness antibacterial and antiviral needs.

Method used

Developed a resin composition containing monovalent copper compound particles as antibacterial antiviral agents, by adjusting the color brightness (L* value) to 0 or more and less than in the L*a*b* color system of JIS Z 8781-4 40. Combined with black pigments, improve its antibacterial and antiviral properties.

Benefits of technology

It achieves higher antibacterial and antiviral properties, can effectively produce bactericidal effects on a variety of viruses and bacteria, and is suitable for a variety of products such as fibers, membranes and sheets.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005068426470000131
    Figure BDA0005068426470000131
  • Figure BDA0005068426470000141
    Figure BDA0005068426470000141
Patent Text Reader

Abstract

The invention provides a novel antibacterial and antiviral resin composition. The antibacterial and antiviral resin composition according to the present invention is a resin composition having antibacterial and antiviral properties and containing monovalent copper compound particles as an active ingredient, wherein the L * value in the L * a * b * color system according to JIS Z 8781-4 is 0 or more and less than 40.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to an antibacterial and antiviral resin composition capable of inactivating attached bacteria and viruses. Background Art

[0002] Due to the COVID-19 pandemic, our lifestyles have changed significantly. Masks and disinfectants have become necessary in daily life, and general consumers are also paying close attention to antiviral products, which have been of great concern to medical professionals. Among them, the demand for air purifiers and air conditioners used to regulate indoor environments has increased, and the demand for not only antibacterial properties but also antiviral functions is increasing.

[0003] In order to solve these problems, molded products such as filters and antiviral membranes having antibacterial and antiviral properties have been developed (for example, Patent Documents 1, 2, and 3). Prior art literature Patent Literature

[0004] Patent Document 1: International Publication No. 2011 / 040048 Patent Document 2: Japanese Patent Application Publication No. 2005-007346 Patent document 3: Japanese Patent Application Publication No. 2021-066874. Summary of the invention Problem that the invention aims to solve

[0005] From the viewpoint of freedom in product design, etc., it is preferable to have more choices for materials having antibacterial and antiviral properties. The object of the present invention is to provide a novel antibacterial and antiviral resin composition.

[0006] The present inventors have conducted intensive studies and have found that when a resin composition having an L* value of 0 or more and less than 40 in the L*a*b* colorimetric system of JIS Z 8781-4 contains monovalent copper compound particles as an antibacterial and antiviral agent, the resin composition exhibits higher antibacterial and antiviral properties than a resin composition containing monovalent copper compound particles but not satisfying the above L* value range, thereby completing the present invention. Means for solving problems

[0007] The gist of the present invention is as follows. [1] An antibacterial and antiviral resin composition, comprising monovalent copper compound particles as an effective component and having antibacterial and antiviral properties, wherein the L* value in the L*a*b* colorimetric system of JIS Z 8781-4 is greater than or equal to 0 and less than 40. [2] The antibacterial and antiviral resin composition according to [1], comprising a black pigment. [3] The antibacterial and antiviral resin composition according to [1], which is dyed with a black dye. [4] The antibacterial and antiviral resin composition according to any one of [1] to [3], wherein the antibacterial and antiviral resin composition is a fiber, a film or a sheet. [5] The antibacterial and antiviral resin composition according to [1], wherein the monovalent copper compound particles are chloride, acetate, sulfide, iodide, bromide, peroxide, oxide, thiocyanate or a mixture thereof. [6] An antibacterial and antiviral resin composition according to [1], wherein the monovalent copper compound particles contain particles of one or more compounds selected from the group consisting of CuCl, CuOCCH3, CuI, CuBr, Cu2O, Cu2S and CuSCN. [7] The antibacterial and antiviral resin composition according to [1], comprising CuI particles as the monovalent copper compound particles. [8] The antibacterial and antiviral resin composition according to [1], comprising one or more selected from carbon black, titanium black and phthalocyanine. Effects of the Invention

[0008] According to the present invention, a novel antibacterial and antiviral resin composition can be provided. DETAILED DESCRIPTION

[0009] Hereinafter, the antibacterial and antiviral resin composition according to the present embodiment will be described in detail.

[0010] First, the antibacterial and antiviral resin composition of the present embodiment includes a resin and monovalent copper compound particles, and has an L* value of 0 or more and less than 40 in the L*a*b* color system of JIS Z 8781-4.

[0011] In the L*a*b* color system of JIS Z 8781-4, which is the Japanese Industrial Standard, the L* value represents the lightness (brightness) of a color, and the a* value and the b* value represent the chromaticity, which shows the hue and the saturation. The antibacterial and antiviral resin composition of the present embodiment having an L* value of 0 or more and less than 40 in JIS Z 8781-4 has, for example, a black appearance.

[0012] For the resin combination of the present embodiment, in order to make the L* value in the L*a*b* color system of JIS Z 8781-4 be more than 0 and less than 40, for example, a dye / pigment can be used to color the resin combination. Wherein, from the viewpoint of durability, it is preferred to use a pigment (organic pigment, inorganic pigment). In addition, it is also possible to mix a plurality of color dyes / pigments so that the L* value in the L*a*b* color system of JIS Z8781-4 is more than 0 and less than 40. It should be noted that the L* value in the L*a*b* color system specified in JIS Z 8781-4 can be measured, for example, using a colorimeter. In addition, when the resin composition is colored using a dye / pigment, the content of the dye / pigment is not particularly limited, and for example, the L* value is adjusted to be greater than 0 and less than 40 according to the measured value of the colorimeter. For example, in a 100% by mass antibacterial and antiviral resin composition, the dye / pigment may be greater than 0.05% by mass and less than 2.0% by mass, preferably greater than 0.1% by mass and less than 1.5% by mass.

[0013] Examples of organic pigments include azo pigments, phthalocyanine pigments, polycyclic pigments (quinacridone pigments, perylene pigments, perinone pigments, isoindolinone pigments, isoindolinone pigments, dioxazine pigments, thioindigo pigments, anthraquinone pigments, quinophthalone pigments, metal complex pigments, diketopyrrolopyrrole pigments, etc.), dye lake pigments, and the like.

[0014] Examples of the inorganic pigment include metal oxide powders, metal sulfide powders, and metal powders such as barium sulfate, zinc white, lead sulfate, yellow lead, zinc yellow, red iron (red iron (III) oxide), cadmium red, ultramarine, Prussian blue, chromium oxide green, cobalt green, umber, carbon black, bone black, graphite, titanium black, iron black, synthetic iron black, titanium oxide, and iron tetroxide.

[0015] Examples of the dye include azo dyes, anthraquinone dyes, phthalocyanine dyes, quinoneimine dyes, quinoline dyes, nitro dyes, carbonyl dyes, and methine dyes.

[0016] Among them, from the viewpoint of improving the antiviral and antibacterial properties, it is preferred to contain one or more selected from carbon black, titanium black and phthalocyanine.

[0017] The resin constituting the resin composition of the present embodiment is not particularly limited and can be appropriately selected. For example, thermoplastic resins such as polyethylene resin, polypropylene resin, polystyrene resin, ABS resin, AS resin, AES resin, EVA resin, polymethylpentene resin, polyvinyl chloride resin, polyvinylidene chloride resin, polymethyl acrylate resin, polyvinyl acetate resin, polyamide resin, polyimide resin, polycarbonate resin, polyethylene terephthalate resin, polybutylene terephthalate resin, polyacetal resin, polyarylate resin, polysulfone resin, etc.; styrene elastomers such as silicone resin and polystyrene elastomer; olefin elastomers such as polyethylene elastomer and polypropylene elastomer; polyurethane elastomers such as polyurethane elastomer; thermoplastic elastomers such as vinyl chloride elastomer, polyester elastomer, and nylon elastomer.

[0018] In addition, the antibacterial and antiviral resin composition of the present embodiment includes monovalent copper compound particles as antibacterial and antiviral agents. It is known that monovalent copper compound particles originally have very high antibacterial and antiviral properties, and its mechanism is still unclear, but it is believed that: if in contact with moisture in the air or in droplets, monovalent copper ions are dissolved, and the dissolved monovalent copper ions release electrons by contacting bacteria and viruses, and some damage is caused by the active species generated at this time. As monovalent copper compound particles, specifically, chlorides, acetates (acetic acid compounds), sulfides, iodides, bromides, peroxides, oxides, thiocyanates or mixtures thereof are preferred. Among them, from the viewpoint of improving antiviral and antibacterial properties, more preferably monovalent copper compound particles are selected from at least one of CuCl, CuOCCH3, CuI, CuBr, Cu2O, Cu2S and CuSCN, and more preferably particles containing CuI (copper iodide (I)).

[0019] The content of the monovalent copper compound particles in the antibacterial and antiviral resin composition of this embodiment can be appropriately set according to the desired antibacterial and antiviral properties. For example, relative to 100% by mass of the antibacterial and antiviral resin composition, it can be 0.5% by mass or more and less than 40% by mass, preferably 1% by mass or more and less than 8% by mass. The particle size of the monovalent copper compound particles is not particularly limited, and those skilled in the art can appropriately set it, preferably the average particle size is more than 1nm and less than 500nm. This is because, when the average particle size is less than 1nm, the material becomes unstable, and when the average particle size is more than 500nm, the antibacterial and antiviral effects are lower than those less than 500nm. It should be noted that in this specification, the average particle size refers to the volume average particle size. The volume average particle size can be measured, for example, based on the laser Doppler method (dynamic electrophoretic light scattering method). The measuring device is not particularly limited, for example, a Zeta potential particle size measurement system (made by Otsuka Electronics) can be used.

[0020] The antibacterial and antiviral resin composition of the present embodiment does not involve the type of genome, the presence or absence of the envelope, etc., and can reduce the infectivity of various viruses or inactivate various viruses. As the virus, for example, rhinovirus, poliovirus, foot-and-mouth disease virus, rotavirus, norovirus, enterovirus, hepatovirus, astrovirus, zaru virus, hepatitis E virus, influenza A / B / C virus, parainfluenza virus, mumps virus (epidemic mumps), measles virus, human metapneumovirus, RS virus, Nipah virus, Hendra virus, yellow fever virus, dengue virus, Japanese encephalitis virus, West Nile virus, hepatitis B / C virus, eastern and western equine encephalitis virus, Agnang-Nyanong virus, rubella virus, Lassa virus, Junin virus, Machupo virus, Guanarito virus, Sabia virus, Crimean-Congo hemorrhagic fever virus, sand fly fever, Hantavirus, Sin Noble virus, rabies virus, Ebola virus, Marburg virus, bat lyssavirus, human T-cell leukemia virus, human immunodeficiency virus, human coronavirus, SARS coronavirus, human parvovirus, polyomavirus, human papillomavirus, adenovirus, herpes virus, varicella, herpes zoster virus, Epstein-Barr virus, cytomegalovirus, smallpox virus, monkeypox virus, vaccinia virus, Morasipox virus, parapox virus, Zika virus, new coronavirus (covid-19), etc.

[0021] Furthermore, the antibacterial and antiviral resin composition of the present embodiment is not particularly limited to the bacteria that can be inactivated, and can sterilize various bacteria regardless of the properties such as Gram-positive / negative, aerobic / anaerobic, etc. Specific bacteria include, for example, Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus, Pneumococcus, influenza bacteria, pertussis bacteria, enteritis bacteria, Klebsiella pneumoniae, Pseudomonas aeruginosa, Vibrio, Salmonella, cholera bacteria, Shigella dysenteriae, anthrax bacteria, tuberculosis bacteria, Clostridium botulinum, tetanus bacteria, and Streptococcus.

[0022] The resin combination of the present embodiment can contain other components except monovalent copper compound particles. As other components, plasticizer, desiccant, curing agent, anti-skinning agent, flattening agent, anti-dripping agent, mildew inhibitor, ultraviolet absorber, heat ray absorber, lubricant, surfactant, thickener, viscosity regulator, stabilizer, drying regulator, pigment, dispersant, mildew-proof composition, antiallergic composition, catalyst, anti-reflective material, material with heat insulation properties can be cited. Other components can also include more than 2 kinds. The mode containing other components is not particularly limited, can be dispersed in the inside of the resin combination, can also make a part of other components dispersed in the inside of the resin combination exposed from the surface of the resin combination, can also be fixed on the surface of the resin combination. It should be noted that the antibacterial and antiviral resin composition of the present embodiment can also be made into fibers or fiber structures in addition to, for example, films, sheets, and molded bodies. As fibers, short fibers can be long fibers, and monofilaments can be multifilaments. As fiber structures, cloth, woven fabrics, nonwoven fabrics, mixed paper, etc. can be listed.

[0023] Next, an example of a method for producing the antibacterial and antiviral resin composition of the present embodiment will be described in detail. It should be noted that the following description will be given by taking the case where the antibacterial and antiviral resin composition of the present embodiment is formed into fibers as an example.

[0024] First, master batch particles are prepared in which monovalent copper compound particles as an antibacterial and antiviral agent are mixed (dispersed). The master batch particles are prepared, for example, as follows.

[0025] The crushed monovalent copper compound particles are mixed with a known dispersant, and after the surface of the monovalent copper compound particles is coated with the dispersant, the monovalent copper compound particles are mixed with resin particles, and the monovalent copper compound particles are dispersed in the interior of the resin particles by using a mixing extruder. Alternatively, by mixing the crushed monovalent copper compound particles and the dispersant with the resin particles and using a mixing extruder, during the mixing process, the dispersant is attracted to the monovalent copper compound particles, and as a result, the monovalent copper compound particles are covered with the dispersant, and the monovalent copper compound particles are dispersed in the interior of the resin particles. After the mixture is cooled, the resin containing the monovalent copper compound particles is shredded using a granulator to obtain master batch particles mixed (dispersed) with the monovalent copper compound particles. It should be noted that those skilled in the art can appropriately set the ratio (concentration) of the monovalent copper compound particles when manufacturing the master batch particles.

[0026] The obtained masterbatch particles are melt-kneaded with the above-mentioned dye / pigment, resin, and other components as needed using a molding machine to manufacture a spinning raw material. And, by supplying the obtained spinning raw material to a melt spinning process, the fiber of the present embodiment can be obtained. The melt spinning method is not limited to a specific method, and a known method can be used. Regarding the spinning temperature, as long as it can be ejected from the spinneret under a state where the resin viscosity is moderately low and does not cause degradation of the resin, thermal decomposition, and the spinning process will not be significantly unstable, and a high-strength fiber can be obtained by subsequent stretching treatment, then the temperature region suitable for the fiber material can be appropriately selected.

[0027] In the melt spinning process, the spinning raw material is ejected from the spinneret, and the ejected fibrous spinning raw material is cooled and solidified to form a fiber. Specifically, the ejected spinning raw material is cooled to below the solidification temperature in a medium such as air, water, glycerin, etc. to solidify it. In the case of water-cooled cooling, by heating to about 60°C and slowly cooling, the fiber can pass through the water tank without shaking when introduced into the water tank, so the stability during cooling is excellent. In the case of air cooling, the temperature and wind speed of the air can be set arbitrarily, but in order to suppress molecular orientation, it is preferred that the wind speed is low and the temperature is not too low. If the degree of molecular orientation is high at the moment of cooling, then in the case of a heating and stretching process in the next process, it is sometimes difficult for the fiber to be stretched, and it is difficult to obtain an antibacterial and antiviral effect.

[0028] Then, the solidified fiber is wound. The winding speed can be set to any speed. However, when the winding speed is lower than the free falling speed of the molten undrawn yarn, uniform undrawn yarn may not be obtained, resulting in reduced stretchability. It should be noted that when a heating and drawing step is performed in the next step, the solidified yarn may be directly supplied to the heating and drawing step without being wound.

[0029] Next, the heating and stretching process is described. The heating and stretching process is a process of heating and stretching the fiber (unstretched yarn) wound in the spinning process. The heating and stretching process may have multiple stretching processes. In the case where the heating and stretching process has multiple stretching processes, the product of the stretching ratios in each stretching process is the total stretching ratio. In addition, in the case where the heating and stretching process is composed of one stretching process, the stretching ratio in the one stretching process is the total stretching ratio.

[0030] The fiber of an example of the antibacterial and antiviral resin composition of the present embodiment shows more excellent antibacterial and antiviral properties by heating and stretching, and can efficiently inactivate bacteria and viruses attached to the fiber surface, etc. In particular, when the fiber is a monofilament, the antibacterial and antiviral effect can be further improved by heating and stretching. The mechanism of greatly improving the antibacterial and antiviral effect by heating and stretching is not clear at present, but it is considered to be the following reasons. In the spinning process, when the fiber in the molten state starts to cool, the surface layer of the fiber is directly cooled and solidified, and the antibacterial and antiviral agent present in the part (inner layer) on the inner side of the fiber closer to the surface layer becomes a structure that is difficult to contact with the moisture outside the fiber. On the other hand, the inner layer is cooled and solidified via the surface layer, so the cooling rate of the inner layer is lower than the cooling rate of the surface layer. Therefore, it is believed that the fiber structure of the surface layer is different from the fiber structure of the inner layer. If heated and stretched in this state, it is stretched under heating conditions above the glass transition temperature, so the fiber structure of the surface layer becomes a fiber structure that the antibacterial and antiviral agent is easily contacted with the moisture outside the fiber. Furthermore, since the fiber structure of the surface layer is brought close to that of the inner layer by heat stretching, it is considered that the surface charges, DNA, etc. of bacteria and viruses are affected to some extent and inactivated.

[0031] The stretching method is not particularly limited, and known stretching methods such as hot roll stretching, hot plate stretching, tubular stretching, stretch blow molding, laser stretching, etc. can be appropriately adopted. In the case of heat stretching by hot roll stretching, the unstretched yarn can be stretched to a high ratio by changing the rotation speed of the hot rolls combined into multiple stages.

[0032] The stretching ratio is appropriately selected according to the fineness of the stretched object. Usually, the total stretching ratio is set to more than 3.0 and less than 7.0 times, preferably set to more than 4.0 and less than 6.0 times. By making the stretching ratio more than 3.0 and less than 7.0 times, the molecules are further oriented, and a fiber with higher strength can be obtained. When the stretching ratio is less than 3.0 times, compared with the case where the stretching ratio is more than 3.0 times, the antibacterial and antiviral effect is low, and the strength of the obtained fiber is reduced. In addition, when the stretching ratio exceeds 7.0 times, the tensile tension becomes extremely high, so sometimes the situation of broken silk occurs frequently and the silk making property is reduced.

[0033] It should be noted that the fiber as an example of the antibacterial and antiviral resin composition of the present embodiment may have a core-sheath structure. In this case, for example, the core is formed by a common resin (a resin that does not contain monovalent copper compound particles), and the sheath contains monovalent copper compound particles, and is formed by a resin having an L* value of 0 or more and less than 40 in the L*a*b* color system of JIS Z8781-4, thereby having the advantage of not only being able to improve the strength of the fiber, but also being able to reduce the content of monovalent copper compound particles. The resin of the core and the resin of the sheath may be the same or different resins.

[0034] The cross-sectional shape of the fiber of core-sheath structure orthogonal to the length direction is not particularly limited, and the cross-sectional shape is preferably set to a circle, and the core and the sheath are preferably also formed into concentric circles. In the cross section orthogonal to the length direction of the fiber, the ratio of the area of ​​the core to the area of ​​the sheath is not particularly limited and can be appropriately set by the user.

[0035] The fiber as an example of the antibacterial and antiviral resin composition of the present embodiment can be used as fabrics, woven fabrics, non-woven fabrics, mixed paper and other papers. In addition, the fiber can be used for sheet products such as clothing, bedding, sleeping materials, masks, handkerchiefs, towels, carpets, curtains, outer wall materials, building materials, interior materials, etc., filters for air purifiers, air conditioners, ventilators, electric vacuum cleaners, electric fans, air conditioners, vehicles, etc., fish ponds, fixed nets and other fishing nets, filters for water treatment, filters for drinking water, filters for ballast water treatment, protective clothing, protective nets, insect-proof nets, chicken coops and other products. Therefore, the fiber as an example of the antibacterial and antiviral resin composition of the present embodiment is a useful material that can provide various products with excellent performance in various fields. Example

[0036] Next, the present invention will be described in more detail with reference to examples, but the present invention is not limited to these examples.

[0037] (Example 1) Copper (I) iodide was used as the monovalent copper compound particles. Polyethylene masterbatch particles (Cufitec (registered trademark) MB-PE manufactured by NBCmeshtec) containing copper (I) iodide (particle size: 350 nm) as an effective ingredient: 5 wt%, polypropylene masterbatch particles containing carbon black pigment: 5 wt%, and polypropylene resin: 90 wt% were melted and mixed. The obtained mixture was melted using a melt extruder provided in a melt spinning device, ejected from a spinneret provided in the melt spinning device, cooled in a water tank and taken out at a predetermined speed, thereby obtaining an antibacterial and antiviral fiber as a resin composition. The obtained antibacterial and antiviral fiber had a fiber diameter of 150 μm. The black pigment accounted for 1.0 mass % of 100 mass % of the obtained antibacterial and antiviral fibers. In addition, the content of copper (I) iodide in 100% by mass of the obtained antibacterial and antiviral fibers was 2.0% by mass. The obtained antibacterial and antiviral fiber was measured for its L* value in the L*a*b* colorimetric system specified in JIS Z 8781-4 using a colorimeter (manufactured by Konica Minolta, color measurement device CR-10 (colorimeter), the same below), and the result was L*=16.5.

[0038] (Example 2) The antibacterial and antiviral fibers were prepared in the same manner as in Example 1 except that the polypropylene masterbatch containing carbon black-based black pigment was changed to a polypropylene masterbatch containing titanium black-based black pigment: 1.5 wt%, and the polypropylene resin: 93.5 wt%. The fiber diameter of the obtained antibacterial and antiviral fibers was 150 μm, and the L* value in the L*a*b* colorimetric system specified in JIS Z 8781-4 was measured at this time, and the result was L*=1.8. The black pigment accounted for 0.3% by mass in 100% by mass of the obtained antibacterial and antiviral fibers. In addition, the content of copper (I) iodide in 100% by mass of the obtained antibacterial and antiviral fibers was 2.0% by mass.

[0039] (Example 3) The antibacterial and antiviral fibers were prepared in the same manner as in Example 1 except that the polypropylene masterbatch containing carbon black black pigment was changed to a polypropylene masterbatch containing phthalocyanine black pigment: 1.0 wt%, and the polypropylene resin: 94 wt%. The fiber diameter of the obtained antibacterial and antiviral fibers was 150 μm, and the L* value in the L*a*b* colorimetric system specified in JIS Z 8781-4 was measured at this time, and the result was L*=35. The black pigment accounted for 0.2% by mass in 100% by mass of the obtained antibacterial and antiviral fibers. In addition, the content of copper (I) iodide in 100% by mass of the obtained antibacterial and antiviral fibers was 2.0% by mass.

[0040] (Example 4) Copper (I) iodide was used as monovalent copper compound particles. Polyethylene masterbatch particles (Cufitec (registered trademark) MB-PE manufactured by NBCmeshtec) containing copper (I) iodide (particle size: 350nm) as an effective ingredient: 5wt%, polypropylene masterbatch particles containing carbon black black pigment: 5wt%, and polyethylene resin: 90wt% were melted and mixed. The obtained mixture was filmed using a twin-screw extruder (LABOPLASTOMILL (registered trademark) manufactured by Toyo Seiki Co., Ltd.) to obtain an antibacterial and antiviral film as a resin composition of Example 4. The thickness of the obtained film was 120μm, and the copper (I) iodide was 2.0% by mass in the 100% by mass antibacterial and antiviral film. The L* value in the L*a*b* color system specified in JIS Z 8781-4 was measured at this time, and the result was L*=35.6. The amount of the black pigment in 100% by mass of the obtained antibacterial and antiviral film was 1.0% by mass. In addition, the content of copper (I) iodide in 100% by mass of the obtained antibacterial and antiviral film was 2.0% by mass.

[0041] (Comparative Example 1) The spinning was carried out in the same manner as in Example 1 except that no carbon black pigment was added, thereby obtaining the antibacterial and antiviral fiber of Comparative Example 1. The fiber diameter of the obtained antibacterial and antiviral fiber was 150 μm. The obtained antibacterial and antiviral fiber was measured for its L* value in the L*a*b* color system specified in JIS Z 8781-4 using a colorimeter. The result was L*=85.2. In addition, the content of copper (I) iodide in 100% by mass of the obtained antibacterial and antiviral fibers was 2.0% by mass.

[0042] (Comparative Example 2) The spinning was carried out in the same manner as in Example 2 except that no titanium black pigment was added, thereby obtaining the antibacterial and antiviral fibers of Comparative Example 2. The fiber diameter of the obtained antibacterial and antiviral fibers was 150 μm. The obtained antibacterial and antiviral fiber was measured for its L* value in the L*a*b* color system specified in JIS Z 8781-4 using a colorimeter. The result was L*=57.3. In addition, the content of copper (I) iodide in 100% by mass of the obtained antibacterial and antiviral fibers was 2.0% by mass.

[0043] (Comparative Example 3) The spinning was carried out in the same manner as in Example 3 except that the phthalocyanine black pigment was not added, thereby obtaining the antibacterial and antiviral fibers of Comparative Example 3. The fiber diameter of the obtained antibacterial and antiviral fibers was 150 μm. The obtained antibacterial and antiviral fiber was measured for its L* value in the L*a*b* color system specified in JIS Z 8781-4 using a colorimeter. The result was L*=63.1. In addition, the content of copper (I) iodide in 100% by mass of the obtained antibacterial and antiviral fibers was 2.0% by mass.

[0044] (Comparative Example 4) The same method as in Example 4 was used to form a film except that no carbon black pigment was added to obtain an antibacterial / antiviral film of Comparative Example 4. The thickness of the obtained antibacterial / antiviral film was 120 μm, and the L* value in the L*a*b* color system specified in JIS Z8781-4 was measured using a colorimeter, and the result was L*=61.7. In addition, the content of copper (I) iodide in 100% by mass of the obtained antibacterial and antiviral film was 2.0% by mass.

[0045] (Comparative Example 5) The spinning was carried out in the same manner as in Example 1 except that masterbatch particles containing copper (I) iodide (particle size: 350 nm) as an active ingredient were not added and the amount of polyethylene resin was changed to 95 wt %, thereby obtaining fibers of Comparative Example 4. The obtained fibers had a fiber diameter of 150 μm. The obtained antibacterial and antiviral fiber was measured for its L* value in the L*a*b* color system specified in JIS Z 8781-4 using a colorimeter. As a result, L*=7.6. The black pigment accounted for 1.0 mass % of 100 mass % of the obtained fiber.

[0046] <Determination of antiviral activity> The antiviral properties in Examples 1 to 4 and Comparative Examples 1 to 5 were measured using influenza virus in accordance with JIS L1922 "plaque assay method". The results are shown in Table 1. In addition, the standard cloth used as a control was a test-use white cotton cloth (Canequim No. 3) in accordance with JIS L0803.

[0047] [Table 1]

[0048] As can be understood from Table 1, excellent antiviral performance was shown in all Examples containing monovalent copper compound particles as an antiviral agent and having an L* value of 0 or more and less than 40. In contrast, even if monovalent copper compound particles as an antiviral agent were contained, in Comparative Examples 1 to 4 having an L* value of more than 40, the antiviral properties were lower than those of Examples 1 to 4. In addition, although the L* value was 0 or more and less than 40, no antiviral effect was observed in Comparative Example 5 that did not contain monovalent copper compound particles as an antiviral agent.

[0049] <Determination of antibacterial properties> The antibacterial properties in Examples 1 to 4 and Comparative Examples 1 to 5 were measured using Staphylococcus aureus in accordance with JIS L 1902. The results are shown in Table 2.

[0050] [Table 2]

[0051] As can be understood from Table 2, Examples 1 to 4, which contain monovalent copper compound particles as an antibacterial agent and have an L* value of 0 or more and less than 40, show excellent antibacterial properties below the detection limit or 3LogCFU within 18 hours. In contrast, even if monovalent copper compound particles are contained as an antibacterial agent, in Comparative Examples 1 to 4, where the L* value is higher than 40, the antibacterial properties are lower than those of all the examples. In addition, in Comparative Example 5, where the L* value is 0 or more and less than 40 but does not contain monovalent copper compound particles as an antibacterial agent, bacteria proliferate.

Claims

1. An antibacterial and antiviral resin composition, comprising monovalent copper compound particles as an effective ingredient, having antibacterial and antiviral properties, wherein: The L* value in the L*a*b* colorimetric system of JIS Z 8781-4 is 0 or more and less than 40. 2 . The antibacterial and antiviral resin composition according to claim 1 , comprising a black pigment. The antibacterial and antiviral resin composition according to claim 1 , which is dyed with a black dye.

4. The antibacterial and antiviral resin composition according to any one of claims 1 to 3, wherein The antibacterial and antiviral resin composition is in the form of fiber, film or sheet.

5. The antibacterial and antiviral resin composition according to claim 1, wherein The monovalent copper compound particles are chloride, acetate, sulfide, iodide, bromide, peroxide, oxide, thiocyanate or a mixture thereof.

6. The antibacterial and antiviral resin composition according to claim 1, wherein The monovalent copper compound particles include particles of one or more compounds selected from the group consisting of CuCl, CuOCCH3, CuI, CuBr, Cu2O, Cu2S and CuSCN.

7. The antibacterial and antiviral resin composition according to claim 1, wherein The monovalent copper compound particles include particles containing CuI. 8 . The antibacterial and antiviral resin composition according to claim 1 , comprising one or more selected from the group consisting of carbon black, titanium black and phthalocyanine.